Contraceptive Technology Update – August 1, 2020
August 1, 2020
View Issues
-
Guidance Helps Clinicians Counsel Transgender Patients on Contraception
One of the challenges facing family planning clinics and obstetricians/gynecologists when serving transgender and gender-diverse patients is the lack of research and evidence-based guidelines to inform their clinical decisions. More research is needed about contraceptive needs and health effects on transgender and gender-diverse people, experts say.
-
Clinicians Can Follow Recommendations to Better Serve Transgender Populations
Family planning clinicians and obstetrician/gynecologists likely will see transgender or gender-diverse patients seeking contraceptive care. Clinicians should learn more about transgender and gender-diverse patients to better inform their care of these populations.
-
Words and Phrases Related to Transgender Care
Researchers and organizations that advocate for the transgender and gender-diverse communities provide these words and definitions to educate people about the transgender community. They offer suggested sexual health language that is respectful of transgender and gender-diverse patients.
-
Can COVID-19 Be Transmitted Sexually?
Researchers are beginning to investigate whether COVID-19 can be transmitted sexually. Early data from the study, as well as data from research in China, show the virus is present in some men’s semen. But other researchers who studied men who had recovered from COVID-19 did not find virus in semen samples. Authors of a new study hope to settle the question and answer questions about the transmissibility in semen.
-
Intervention Reduces Pregnancy and STI Risk Among Young Women with Depression
Young women with depression experience a higher rate of unintended pregnancy and sexually transmitted infections than young women, in general. The challenge for family planning clinicians is to find an effective intervention to help them prevent pregnancy and maintain their health.
-
An Over-the-Counter Progestin-Only Pill Would Appeal to Millions
In a model based on a national survey of 2,539 reproductive-age women in the United States, an over-the-counter, progestin-only contraceptive pill would appeal to 12.5 million adults and 1.75 million teens, assuming there were no out-of-pocket costs.
-
We’d Love to Hear from You!
Please take five minutes to complete our annual user survey (https://bit.ly/2XYHWdM), and we’ll enter you to win a yearlong subscription to Relias Media.